Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

S1 2019 Earnings Call
Company Participants
FINAL

Denis Kessler, Chairman of the Board and Chief Executive Officer
Francois de Varenne , Chief Executive Officer of SCOR Global Investments
Frieder Knupling, Chief Risk Officer
Ian Kelly, Head of Investor Relations
Jean-Paul Conoscente , Chief Executive Officer of SCOR Global P&C
Laurent Rousseau, Deputy Chief Executive Officer of SCOR Global P&C
Mark Kociancic, Chief Financial Officer
Paolo De Martin, Chief Executive Officer of SCOR Global Life
Unidentified Speaker

Other Participants
Andrew Ritchie , Analyst
Frank Kopfinger, Analyst
James Shuck, Analyst
Jonny Urwin, Analyst

Bloomberg Transcript

Kamran Hossain, Analyst
Sami Taipalus , Analyst
Vikram Gandhi, Analyst
Vinit Malhotra, Analyst
William Hawkins , Analyst

Presentation
Operator
Good day, ladies and gentlemen, and welcome to the SCOR Group Q2 Results
Conference Call. Today's call is being recorded. There will be an opportunity to ask
questions after the presentation. To provide all participants an opportunity to place the
question, please kindly limit your number of questions placed to two questions.
At this time, I would like to hand the call over to Mr. Ian Kelly, Head of Investor Relations.
Please go ahead, sir.

Ian Kelly

{BIO 19976646 <GO>}

Good morning, everybody, and welcome to the SCOR Group first half of 2019 results call.
And I please ask you to consider the disclaimer on Page 2 of the presentation, which
Page 1 of 20



Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

indicates that the financial results for the first half of 2019 included in this presentation
have been subject to the completion of a limited review by SCOR's independent auditors.

FINAL

With this, I would like to give the floor to Mr. Denis Kessler, CEO and Chairman of the
SCOR Group, who is joined on this call by the COMEX team, Denis?

Denis Kessler

{BIO 1498477 <GO>}

Thank you, Ian, and good morning everyone. Thank you, Ian, and good morning everyone.
SCOR delivers a strong performance in the first half of 2019, successfully combining
strong growth, excellent profitability and robust solvency. SCOR has continued to expand
and deepen its franchise, writing more than EUR8 billion of gross written premiums in H1
2019. This is an increase of 2.6% at constant exchange rates, driven by excellent growth of
SCOR Global P&C of 10.4%, resulting from successful renewals in an improving rating
environment.

Bloomberg Transcript

The SCOR Global Life gross of minus 2.6% at constant exchange rates reflects financial
solutions deals renewing as fees and we told you about this already in Q1. As this is
renewed as premium on a like-for-like basis with last year, comparable life gross would
stand at 3.8%, plus 3.8%, and the Group overall gross would be 6.5% at constant
exchange rates.
The profitability is excellent with a net income of EUR286 million year-to-date at the end
of H1 2019, translating into a return on equity of 9.8% or 908 basis points over the fiveyear risk-free rates and this is well above the Vision in Action profitability target of 800
basis points over risk-fee.
The technical profitability of the business engines is strong, with an excellent P&C
combined ratio of 93.7%, better than assumptions of 95% to 96%. A strong life technical
margin of 7.2% and a solid return on invested assets of 2.8%. At the same time, the
solvency position is strong at 212%, in the upper part of the 185% to 220% optimal range
of the Group's solvency scale with capital generation helping to offset the impacts of
market movements within the quarter, particularly the decrease in interest rates.
Moving on to Slide 4, this excellent start to 2019 brings a fitting and successful close to
Vision in Action, the plan we launched three years ago and that ended at the end of June.
Across the course of the plan, the Group has had to face many headwinds and you know
it. We have had volatility of the heavy cat loads in 2017 and 2018 while the P&C market
environment has been soft. But here we are now becoming more optimistic. We were in a
low yield environment; we were to face regulatory shocks such as the Ogden rate
change; and also geopolitical uncertainties, such as Brexit.
We have had to face shock of the US tax reform. The plan was called Vision in Action. And
in the face of the shocks we did not standby, we acted with a robust capital shield with
retrocession protection to help absorb the cat losses. We dealt with the US tax reform, by
swiftly setting up the structures to ensure we have a strong capital efficient model going
forward. We created a new direct insurance company in France, to cope with the hard
Page 2 of 20



Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

FINAL

Brexit which is likely to be the case, all the while focusing up on the consistent application
of our strategic cornerstones to profitability expand and deepen the franchise. The
actions resulted in the successful delivery of the two targets of the Group on a normalized
basis over the course of Vision in Action, with an average normalized ROE of 9.5% or 876
basis points of risk-free and an average solvency ratio of 219% in the upper part of the
solvency scale optimum range.
The successful delivery of Vision in Action is created considerable value for our
shareholders. Over the course of the plan, total shareholder return has been 65%
dividends to investors. You can expect us to emphasize value creation when we announce
our new plan at the IR Day in early September, the 4th of September, exactly.
I'll now hand over to Mark for the details of the H1 financials. Mark, the floor is yours.

Mark Kociancic

{BIO 17852409 <GO>}

Bloomberg Transcript

Thank you, Denis, and good morning, everyone. So let's begin on Slide 5. I'll walk you
through the financial highlights of the first half of the year. In H1 2019, SCOR underwrote
EUR8 billion of gross written premiums, representing a 6.3% increase over 2018 at current
exchange rates or 2.6% at constant exchange rates. SCOR Global P&C grew at 13.9% and
SCOR Global Life by 1.2% both at current exchange rates. And SCOR Global P&C delivers
a strong net combined ratio at 93.7%, including a cat ratio of 5.2%.
On a normalized basis, the P&C combined ratio stands at 95.5% in line with the Vision in
Action assumption. The Life technical margin is elevated at 7.2%, slightly above the Vision
in Action assumption, particularly due to the 0.4 percentage point of positive impact for
financial solution deals being renewed in the first half of 2019, as fee business.
SCOR Global Investments delivered a return on invested assets of 2.8%, supported by a
strong recurring yield at 2.6%. Overall SCOR's net income for H1 2019 stands at EUR286
million, up 9.2% compared to 2018. This translates into a return on equity of 9.8% and this
is above our Vision in Action profitability target of 800 basis points, above the five-year
average risk-free rates.
Denis already talked about the solvency position and it remains strong at 212% at the end
of H1 and in the upper part of our optimal range in our solvency scale with market
movement in interest rates and the dividend accrual offsetting the capital generation in
the first half of the year.
Going to Page 7, SCOR has seen strong book value growth over the first half and after
dividend payments, shareholders' equity increased by 4.5% compared to fiscal year 2018
to EUR6.1 billion and this is largely driven by net income of EUR286 million recorded in the
first half of the year. This corresponds to a book value of EUR32.59 per share and the
financial leverage stands at 26.4%, decreasing by 1.1 percentage points compared to the
position at year-end December 31st, 2018 and this is broadly in line with Vision in Action
assumptions.

Page 3 of 20



Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

So let's move on to Page 8. SCOR generated EUR33 million of operating cash flow in the
first half of 2019. SCOR Global P&C's cash flows reflect the claims payments from 2018
nat cat events, and SCOR Global Life cash flow reflects volatility of claim payments and
seasonality in client and tax settlements. Overall, the total liquidity of the Group is strong
and stood at EUR1.7 billion at June 30th.

FINAL

Let me now hand over to Jean-Paul, who will present the results of SCOR Global P&C.

Jean-Paul Conoscente

{BIO 20770277 <GO>}

Bloomberg Transcript

Thank you, Mark. SCOR Global P&C achieved a premium growth of 10.4% constant rate of
exchange for the first half on the back of strong renewals in the US during the second half
of 2018 and globally during the first half of 2019. We expect the premium to normalize
during the rest of the year and to land in the upper part of the 5% to 8% range of Vision in
Action.
From a profitability point of view, we had a good second quarter, yielding a 93.7% net
combined ratio for the first half of 2019. This is decomposed as a 5.2% cat ratio for the
first half, made of 6.5% ratio for Q1 stemming from 2018 loss creep and 4.1 cat ratio in Q2
stemming from the Q2 events in 2019, such as the US tornadoes, floods, floods in Brazil,
storms in Europe. We saw -- we also experienced further loss deterioration on Jebi for an
additional EUR33 million gross loss, with SCOR taking the event as a market loss in $12
billion and $15 billion. However, the loss is now into our retrocession protections and the
net impact to SCOR is nil. We estimate our retrocession protection to be active up to a
market loss for Jebi of about $22 billion market loss. We also experienced additional 2018
loss situation from Typhoon Trami and from the Kuwait floods. However, these losses
were offset by loss improvements from the 2018 California wildfires. As a result, the net
impact of SCOR - to SCOR of the 2018 events for this -- for the second quarter was nil.
The normalized net combined ratio stands at 95.5% for the first half, in line with the 95%
to 96% assumption of Vision in Action.
If you turn to Slide 10, during the June and July, the SCOR Global P&C premium grew 6.2%
at constant rate of exchange. The growth year-to-date stands at 10.2% at the same
constant rate of exchange. Pricing improved 3.8% at these renewals for an overall pricing
improvement year-to-date of 1.7%. We currently see an acceleration of primary insurance
rate hardening especially in the US, following the shrinkage of limits deployed by lead
insurance companies and a struggle for brokers to complete placements. From a
reinsurance point of view, the market is firming more slowly with decreasing commission
on a number of casualty proportional treaties, significant rate online increases on property
cat placements and small commission decreases on proportional property treaties.
In the US, we did not grow the cat portfolio despite the 15% to 25% rate online increases,
achieves on Florence programs because this increase is barely matched to our increased
view of risk coming from increases in loss adjustment expenses as also in inflation.
Similarly, on the rest of our portfolio, we kept a stable portfolio as our share increased last
year, had anticipated rate increases that only materialized this year. As a result, we took
some management actions to curtail the portfolio when increases were insufficient and
increased our share when pricing matched our expectation.
Page 4 of 20



Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

Other areas of note where were grew our Latin America, where we grew 21% on the back
of strong price increases in Puerto Rico, Peru and Chile and Australia, where we grew on
one of our strategic clients. Having now renewed over 95% of our yearly portfolio, we
anticipate the 2020 renewal season optimistically, with expected continued hardening of
primary conditions and an accelerated firming of reinsurance conditions.

FINAL

And now, I hand over to Paolo on for Life.

Paolo De Martin

{BIO 15930577 <GO>}

Bloomberg Transcript

Thank you, Jean-Paul. First of all, I'm proud to say that the teams at SCOR Global Life
successfully delivered Vision in Action. We have achieved or exceeded our assumptions
both in terms of growth and profitability. SCOR Global Life has expanded its franchise,
and client recognition of the strength of our proposition is strong across all geographies.
We will provide more details on our achievement and our strategy going toward at the IR
Day in September.
To go back to the results, in the first half of 2019, we have recorded gross written
premiums of EUR4.6 billion. This is an increase of 1.2% at current exchange, and as already
mentioned, a slight decline of 2.6% at constant exchange rate compared to the same
period last year. As in Q1 2019, this variation is largely driven by certain financial solution
deals which had been renewed as fee business rather than as premiums in the first half of
2019. As you may remember, on these deals, we're now recording similar amount of
profit and no headline premiums. On appendix Page 29 of the presentation, you will find
detail number. Excluding these deals, we have grown by 3.8% in constant exchange rates,
driven by positive business growth in North America and in Asia. This premium growth is in
line with Vision in Action assumption of 5% to 6% over the cycle and translates for 2019 in
an expected normalized growth rate of 2% to 4%.
On the profitability side, the net technical results stands at EUR304 million. The new
business underwritten continues to be above the Group ROE targets. The inforce
performance is solid with US mortality claims roughly a EUR130 million higher than in the
same period in 2018, balanced by active portfolio management and a strong reserve
position. The technical margin stands at 7.2% for the first six months of 2019, and again,
the renewal of the financial solution deals as fee business adds 40 basis points to this
metric. As mentioned at the beginning of my presentation, on this deals we're now
recording similar level of profit on lower headline premiums.
I'll now hand it over to Francois for details on our Investment portfolio.

Francois de Varenne

{BIO 7447858 <GO>}

Thank you, Paolo. Moving on to Slide 12, SCOR Global Investments portfolio reached
EUR27.5 billion at the end of June with an invested assets portfolio of EUR19.5 billion
compared to EUR19.6 billion at the end of March. SCOR Global Investments successfully
completed Vision in Action with an average return on invested assets of 3.1% of the plan,

Page 5 of 20



Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

FINAL

in the upper end of the initial 2.5% to 3.2% range. This was achieved in spite of a
challenging financial and economic environment over the past three years.
The portfolio positioning reflects the current environment. Liquidity stands temporarily at
8% of the invested assets. The share of corporate bond has been reduced by 4 points to
reach 44% and the fixed income portfolio remains of very high quality with a stable
average rating of A+ and the duration of 3.8 years, and highly liquid with financial cash
flows of EUR6.6 billion expected to emerge from the investment portfolio over the next
[ph]two years.
Investment income on invested assets stands at EUR309 million in H1 2019, generating a
return on invested assets of 2.8%. This performance is supported by a strong income
yield which stands at 2.6% in the first half of this year. Our theoretical reinvestment yield
stands at 2.2% at the end of June, reflecting the global decrease of interest rate since the
beginning of the year. Indeed, our reinvestment rate stood at 2.9% at the end of
December 2018 and 2.5% at the end of March. Under current market condition, we
maintain our expectation of an annual return on invested assets in the 2.7% to 3% range
for the full year of 2019 supported by capital gains on mature real estate assets to be
taken in the second half of the year.
With this, I will hand it over to Ian Kelly for the conclusion of this presentation.

Bloomberg Transcript

Ian Kelly

{BIO 19976646 <GO>}

Thank you. Francois. On Page 13, you will find the next scheduled event starting on
September the 4th with our Investor Day to be held here in Paris as well as the
conferences which we are planning to attend for the remainder of 2019.
So with this, we can start the Q&A session. Thank you.

Questions And Answers
Operator
(Operator Instructions) We will now take our first question from Andrew Ritchie from
Autonomous. Please go ahead.

Q - Andrew Ritchie

{BIO 18731996 <GO>}

Hi, there. First question on, you flagged the greater momentum particular in US primary.
Maybe you could just outline how -- what opportunities that generates for SCOR? Is this to
write more proportional business in new lines or I mean, obviously, you didn't grow much
the half year US renewals? But just like how that -- how you think the harder primary
market translates into opportunities for SCOR?
Secondly on Life claims, thanks for flagging the higher US claims, I'm not quite sure what
to do with that information. Are you flagging it and saying we had to work really very hard
Page 6 of 20



Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

to combat the extra claim -- those extra claims, and by the way, there might not be the
ability to do that in future quarters or how should I interpret it? Is there still plenty of room
left, I suppose, to combat if these elevated claims continue? Thanks.

FINAL

A - Denis Kessler

{BIO 1498477 <GO>}

Thanks, Andrew. Certainly on your first question, I'm going to give the floor to Jean-Paul,
but it's extraordinary to see some change of mood on the US market. I mean, we're not
the only one to say that, when you analyze the news flow. We were expecting this term
earlier, to tell you the truth, when we launched Vision in Action three years ago, we were
expecting the cycle to turn, let's say one or two years ago. It was not really the case, it
stabilizes. But now it's stabilized, but now there are lots of signs of firming up, hardening
market and -- as a primary side as you said, but also on the reinsurance side.
So it's quite a change and it only took place in 2019 that we see renewals after renewals
and it's true that this is a change of -- probably good change of the environment. We
believe it is going to go on for 2020, but we will certainly expand more on those issues
when present the new plan.
So you're absolutely right to say this is a change of -- change, I would say, not of your
mood, but I would say it's -- it was the market, it's the new orientation. Jean-Paul, can you
say how we benefit from those changes?

Bloomberg Transcript

A - Jean-Paul Conoscente

{BIO 20770277 <GO>}

Yeah, we are a big proportional write in the US, both on casualty and on property. What
we're seeing on casualty is on the price increases, has been the -- have been significant.
And let's say last year they were probably below the loss inflation that we were seeing
coming through the various losses on casualty. This year we think they're above the loss
inflation, so it's positive.
In addition, the reinsurance commissions are coming down on many treaties. So overall,
we feel fairly positive on the casualty side. On the property side, the rate increases are
very significant as a result of actions by some of the market leaders in the US and in
London. We see price increases that are double-digit and sometimes very high doubledigit.
On the reinsurance conditions though, the commissions have really not moved that much
because of oversupply of capacity, and so we've been very cautious on those, you know
like pushing for larger variations of commissions and when we didn't achieve them, we
just kept our shares constant. This explains the sort of the no -- stability of our portfolio
during this renewal.
Going forward, we expect the firming of the reinsurance conditions to continue and we -you know, the commissions to continue to come down. And then when it happens, we e
will probably increase our share on programs that we view as profitable. So overall, we
remain very optimistic for 2020.

Page 7 of 20



Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

A - Denis Kessler

{BIO 1498477 <GO>}

And Jean-Paul the total -- sorry, go ahead Andrew.

FINAL

Q - Andrew Ritchie

{BIO 18731996 <GO>}

Sorry, I was just clarifying. I mean Jean-Paul, you described yourself as a significant writer
US Casualty, but you're not really. I mean you can underweight US casualty surely for some
time unless...

A - Jean-Paul Conoscente

{BIO 20770277 <GO>}

Well, yeah, underweight relative to our peers. But today we write about 800 million of US
casualty. So we're definitely underweight compared to our peers. But that's a portfolio
been growing over the last three, four years.

Q - Andrew Ritchie

{BIO 18731996 <GO>}

Okay.

A - Denis Kessler

{BIO 1498477 <GO>}

Paolo?

Bloomberg Transcript

A - Paolo De Martin

{BIO 15930577 <GO>}

Yeah, on that $130 million, Andrew, we did experience an unusual degree of volatility in
the first six months. So I thought it was our responsibility to flag it and make sure that we
put it in context on the comparative numbers that we're showing on the disclosure. We're
going to add some more color to the US book as we go, given the size of the US both for
SCOR and we can take on this subject at the Investor Day and maybe discuss it them so.

Q - Andrew Ritchie

{BIO 18731996 <GO>}

Sorry, I'm just still trying to understand, are you flagging something that we should think
about for future periods or...

A - Paolo De Martin

{BIO 15930577 <GO>}

No, I think we remain -- we remain confident as we were in the past. We have extended
optionality in the book, and the book is very well reserved. But the degree of volatility we
experienced in the first six months we thought was sufficiently material to be flagged in
our disclosures. But we remain with the same degree of confidence that we had in the
past around both the optionality and the way the book has been reserve in the past.

Q - Andrew Ritchie

{BIO 18731996 <GO>}

Okay, thanks.

A - Ian Kelly

{BIO 19976646 <GO>}

Thanks, Andrew. Let's go to the next question please.
Page 8 of 20



Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

Operator
Our next question comes from Kamran Hossain from RBC. Please go ahead.

FINAL

Q - Kamran Hossain

{BIO 17666412 <GO>}

Hi, couple of questions, one is just on the, I guess on the reinvestment yield you're
flagging at 2.2%, and that's not surprising given what's happened to yield recently. I guess
you've confirmed 2.7% to 3% for this year. I guess when we're thinking about future years,
do you think a similar run rate to this year would still feel achievable? So that's the first
question. And then second question, just on the price increases you've seen year-to-date.
When do you think we start to see these working through into underlying margins? Thank
you.

A - Denis Kessler

{BIO 1498477 <GO>}

Francois?

A - Francois de Varenne

{BIO 7447858 <GO>}

Bloomberg Transcript

So maybe on the first question, so that stood at we observed since the end of last year, a
significant growth everywhere in the world especially in the US in the Eurozone, a
significant drop in interest rate. Just as a reminder, the ten-year treasury was at 3.2% in
November and is close to 2% today. So what does it mean in practice? I maintain my
expectation for the full year 2019 of an income yield around the 2.5%, so no effect at this
stage.
I think I'll say this, the fixed if income portfolio today is protected by each duration, so
which means that there will be a lag before we see the impact on the income yield, but
this impact, if those market condition are the same in the future, will progressively
materialize in the income yield over the next -- the next three years. So we'll give you a full
update early September but I maintain the same -- the same expectation for the full year
2019% at 2.5% at this stage?

Q - Kamran Hossain

{BIO 17666412 <GO>}

Thank you.

A - Denis Kessler

{BIO 1498477 <GO>}

And, what was the second question, Kamran?

Q - Kamran Hossain

{BIO 17666412 <GO>}

Second question is just you've got -- you've had 1.7 points of price improvement year-todate in P&C. It's just when -- how long do you think it is before we start see this working
through into underlying margins or improvement in normalized margins?

A - Denis Kessler

{BIO 1498477 <GO>}

Page 9 of 20



Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

FINAL

We're taking a cautious view this year. I think in 2018, we were -- when clients were telling
us they are going to see a 10% rate increase on their book, we probably gave them credit
for eight and in reality they probably achieved something like four. So this year when
clients tell us they're going to achieve 12, we probably give them credit for half of that. So
I think we felt that we were probably too optimistic last year and being more prudent this
year.
So in the combined ratio that we're reserving for, there is some conservatism on the
amount of price increases that will flow through the book, and so we're waiting for the full
year to develop before we get in full credit. In addition to this, we've taken a revised view
of the number of perils such as Japanese typhoon, US hurricane in Florida, US wildfire and
other risks. So -- and that's also reflected in the higher loss cost. So you know, again, as
we see portfolio developing throughout the year and we see that maybe we've been too
conservative, we may revise those views, but they will not flow until next year.

Q - Kamran Hossain

{BIO 17666412 <GO>}

All right, thanks very much.

A - Ian Kelly

{BIO 19976646 <GO>}

Okay, thanks. We can go to next question please. Our next question comes from Vinit
Malhotra from Mediobanca. Please go ahead.

Bloomberg Transcript

Q - Vinit Malhotra

{BIO 16184491 <GO>}

Yes, Good morning. Thank you very much. So just on these similar two topic please. Firstly,
Jean-Paul, you mentioned the more conservative view on wildfires, and all this perils, but
equally in the same breath you're releasing sort of positive development from the
California wildfires. So is this just -- could you just to reemphasize, is it just extra
conservative, rebuilding the reserve maybe and is Ogden affecting any of your thinking
please. So that's just, if you don't mind, one area of question.
The second one is for invest in income. The -- there's been -- I mean you've increased
liquidity, you sold maybe corporate bonds of say EUR700 million, duration is reduced.
What are these indications -- I mean reduced duration Francois usually is in anticipation of
interest rate increases. Is it just all these measures are just kind of resetting before the
next plan so you want to manage the risk a bit better or how should we understand these
actions in the quarter? Thank you very much.

A - Denis Kessler

{BIO 1498477 <GO>}

Thanks. So Vinit, maybe we start by Jean-Paul.

A - Jean-Paul Conoscente

{BIO 20770277 <GO>}

Yeah thank you. On the wildfire, there is two different aspects. One is the, our view of risk.
I'd say on a pricing going forward. And there we review our, we have revised our views
and are taking a much more pessimistic view of the risk. With the climate change, we view
this risk as being much more frequent than in the past. And that's reflected in our pricing.
Page 10 of 20



Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

FINAL

In terms of the improvement of the loss estimates for the Q2, this is basically a relocation
of loss between the Camp Fire and the Woolsey Fire and just the way the retrocession
works. This results in the net improvement for SCOR, overall. On your question for
Ogden, we estimate this to have a net impact to SCOR after tax of about EUR14 million
and -- yeah, 1-4, EUR14 million (multiple speakers)

Q - Vinit Malhotra

{BIO 16184491 <GO>}

EUR14 million and this is yet to come or...?

A - Jean-Paul Conoscente

{BIO 20770277 <GO>}

I'm sorry?

Q - Vinit Malhotra

{BIO 16184491 <GO>}

It's yet to come with Ogden.

A - Jean-Paul Conoscente

{BIO 20770277 <GO>}

It's yet to come, yes.

Q - Vinit Malhotra

{BIO 16184491 <GO>}

Yes, thank you.

Bloomberg Transcript

A - Francois de Varenne

{BIO 7447858 <GO>}

On your second question on the -- on what we did during the quarter, so that's true that
global economic growth forecast has been revised in the world by all forecaster since the
beginning of the year, and especially for Europe, US and Asia. Inflation remains contained
even in the US, but somehow bankers have been quick to react and have ability [ph] to do
withstand, so which means that the probability of (inaudible) environments seems to be
back for a while.
So in this context, we are starting -- started to manage actively our credit portfolio, which
mean in practice, if you look at all the figures, we improved the average exposure of
SCOR to credit, so which mean a reduction by 4 points. And we also improved the quality
of this portfolio. But the cancellation of this active management of the corporate bond
portfolio in Q2 translate into a voluntary reduction of this exposure and part of the
proceeds are temporarily kept in cash, pending further reinvestment and I will provide
details of future investment strategy early September with the presentation of the next
strategic plan.

Q - Vinit Malhotra

{BIO 16184491 <GO>}

Okay, thank you very much.

A - Ian Kelly

{BIO 19976646 <GO>}

Thanks Vinit, let's go to the next question.
Page 11 of 20



Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

Operator
Our next question comes from William Hawkins from KBW. Please go ahead.

FINAL

Q - William Hawkins

{BIO 1822411 <GO>}

Hello, gentlemen. Thank you very much. And Paolo, just to come back to what you said to
Andrew, could you clarify please? The EUR130 million you phrase that with reference to
first half last year. What would the figure be relative to an expected loss rates or a neutral
benchmark. I can't remember whether the first half was -- last year was normal or not. So
that's question one. And then question two, again, I appreciate you're not giving us detail
on the Solvency II ratio, but given that there is a lot of moving parts in the numerator and
the denominator, could you just tell us in the first half of this year, how much the SCR has
changed. I think it was EUR4.2 billion at the beginning of the year. So has that part of the
ratio gone up or down, and could you give us a guide on that? Thank you.

A - Paolo De Martin

{BIO 15930577 <GO>}

Yeah, we did -- William, we did use the comparative to prior year because we're not really
disclosing a plan or an expected overall at SCOR. So we thought that was the best way to
flag the volatility was a comparative to prior year. In terms of our internal benchmark,
clearly the two quarters have been above our expectations, and we have taken action in
terms of rate increase to compensate that effect.

Bloomberg Transcript

Q - William Hawkins

{BIO 1822411 <GO>}

So in a sense, the EUR130 million understates the issue, specifically in that portfolio
because it was already above expectations this time last year?

A - Paolo De Martin

{BIO 15930577 <GO>}

I'm not sure, I would use the word understate. It's just a different benchmark.

Q - William Hawkins

{BIO 1822411 <GO>}

Okay, got you. Thank you.

A - Frieder Knupling

{BIO 17247809 <GO>}

So, your question was whether the SCR, how that developed during the first two quarters.
It's significantly up, mainly because of economic movements, the decline in yield curves,
especially US dollar interest rates, mechanically drives the SCR up because of long-term
US dollar denominated exposures which are then discounted at a lower rate, that
increases capital requirements and there was also some growth because of business
growth operating. So in total, the SCR is up by -- is something in the range of about 10%
(multiple speakers) continue.

Q - William Hawkins

{BIO 1822411 <GO>}

Okay, that's great Frieder. Thank you, Frieder, excellent.

Page 12 of 20



Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

A - Ian Kelly

{BIO 19976646 <GO>}

Thanks Will. Let's go to the next question please.

Operator

FINAL

Our next question comes from Jonny Urwin from UBS. Please go ahead.

Q - Jonny Urwin

{BIO 17445508 <GO>}

Hello, good morning. Two from me please. So firstly, the normalized combined ratio is
running at the midpoint of the range at the first-half stage. Is that a fair reflection of the
underlying profitability of the book right now? Are there any unusual attritional losses in
that? I'm just trying to think about what's the right starting point for the new plan?
Secondly, on the casualty book, it's interesting to hear you're a bit more optimistic. I
mean, my sense from you guys is that you were getting a bit more interested when
reinvestment rates are obviously much higher, 3.9% [ph] at the start of the year. It
surprises me a little bit; you're still a bit more optimistic with the yields where they are. So
question, is casualty pricing really that good and where is pricing versus loss cost inflation
at the moment?

Bloomberg Transcript

A - Jean-Paul Conoscente

{BIO 20770277 <GO>}

Urwin, on your first question, I think as a -- as a reminder, we've changed the cat ratio
from 6% to 7% at the beginning of 2019. So in effect when we kept the target combined
ratio between 95% and 96%, we implicitly took into account a 1 point improvement on the
attritional. So that's the first point. So when you say it's within the range, but high, you
should take into account the cat ratio that we're adding to this, is no longer 6% but 7%. In
terms of pricing, I think, I explained that we -- it's possible that our views right now are a
bit conservative. I think we feel like we were better positioned to just let portfolio develop
and make sure the rate increases that we're seeing punctually at different renewals are
actually flowing through the rest of the book and that usually takes six months to 12
months to really start appearing. On your question about casualty, again we, it's more a
question of successful and successive rate increases. We start seeing rate increases on
casualty in 2018. We're seeing this being compounded in 2019 and accelerating. On the
other hand, you're right that the rate of inflation seems to be going down, that the loss
costs are going up. But right now we feel that the rate increases we're seeing are
basically more than compensating that, and yielding a net positive. It's is not all lines of
business. The market is very fragmented, it's different behaviors between D&O, E&O,
umbrella primary, commercial auto. So we're focusing on the segments where we see
these positive improvements.

Q - Jonny Urwin

{BIO 17445508 <GO>}

Thanks. Just a follow up on the first questioning, I appreciate the cat ratio went up, but
just thinking about where we are today, in the midpoint of this range. There is nothing
unusual that we should be thinking about that as a fair reflection of the, sort of underlying
profitability of the book at the moment?

Page 13 of 20



Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

A - Jean-Paul Conoscente

{BIO 20770277 <GO>}

Now, I mean we had some large man made losses this quarter, a large refinery loss in
Philadelphia, some mining losses, a little bit further deterioration on the Boeing loss. So
those were the main events of this quarter. But I'd say it's still within expectations.

FINAL

Q - Jonny Urwin

{BIO 17445508 <GO>}

Okay, thank you.

A - Paolo De Martin

{BIO 15930577 <GO>}

Thanks Jonny, let's go to the next question please.

Operator
Our next question comes from Sami Taipalus from Goldman Sachs. Please go ahead.

Q - Sami Taipalus

{BIO 17452234 <GO>}

Bloomberg Transcript

Yeah, hi, thanks, and good morning, everyone. Just -- my first question just comes back to
the June and July rate increases, and I'm still struggling to square everything up a little bit
here. I think you disclosed your pricing number gross remodeling of loss costs. So is it
possible to just give us that -- give us what the impact would have been or give us some
form stare, at least, what the impact would have been net of remodeling of loss costs at
June and July renewals? So that's number one.
Number two, you're talking about price improvements in the primary space, is it possible
to just give a bit of color about how you're thinking about your own primary business units
in the context of this? So I guess Lloyd's and SBS. Thank you.

A - Unidentified Speaker
Okay. I'll answer the first part of the questions and then I'll hand to Laurent to answer the
second part. On the sort of estimated conservatism we've included in the underwriting
ratio, I can give you an estimate for Florida. We basically estimate that our revised view of
loss costs has added about 5 points of loss ratio. I think for the other programs, it really
varies depending on what the geographical location they're in, if there is a lot of wildfire
and not. So it varies. But just to give you an idea on Florida.

Q - Sami Taipalus

{BIO 17452234 <GO>}

Is it possible to say anything -- so is it possible to say anything at the aggregate level?
Because obviously it's quite difficult to sort of get -- take that 5 points on Florida and
square it up with the 3.8 on aggregate?

A - Jean-Paul Conoscente

{BIO 20770277 <GO>}

The overall US book from a pricing point of view improved about 7% and then we
estimate our revised view of modeling probably adds overall maybe 2 points to 2.5 points
to that.
Page 14 of 20



Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

Q - Sami Taipalus

{BIO 17452234 <GO>}

Okay. Okay, great. Thank you.

FINAL

A - Laurent Rousseau

{BIO 19524847 <GO>}

On the -- on what we see on the primary market. So maybe, first of all, to come back to
Andrew's question on the US, I mean the US markets on the insurance side, renewals
really up till 1st of July. So we've done 90%, if not more of the US market right now and as
Jean-Paul said, we really see double-digit rate increases on large commercial insurance
risk, that's property and casualty driven for the rate increases, there are pretty high.
The second thing that is very beneficiary is the restructuring in those programs. So we see
that retention has been significant increase and we see the reshaping of terms and
conditions impacting the overall economy. But I think that's the first point. We see a lot of
turmoil in the US, in particular, on some of our competitor's risk appetite, in particular large
groups and risk appetite changing.

Bloomberg Transcript

Some of it is really major reaction to claims activity, but for us, I mean our risk appetite has
been very stable and I'm really speaking for SCOR Business Solutions has been very
stable for the past five to 10 years. We didn't grow so much. We grew steadily. So that
market situation is actually quite favorable and we make quite a difference there.
So the rate increases should tail off, I guess in the rest of the year, as Europe and APAC
are going to have a bigger share of our business on insurance and there the rate increase
is, I guess, a bit lower than what we've seen in the US. That was the first answer on SCOR
Business solutions and in the US.
Now on Lloyd's, well first of all it's still linked to the US, we see huge opportunities for us
as the binder businesses at Lloyd's are really being restructured. So our US program
business, the local US program business, based in Chicago and New York is seeing huge
inflow of business, because a number of MGAs are nervous with Lloyd's and the turmoil at
Lloyd's is benefiting us in our local platforms. So we see a good flow of business there.
And here again the rate increases are positive, so that there is very good commercial
traction.
And as far as Lloyd's is concerned for our syndicate SCOR channel and here we continue
our refocus on specialty classes, so political risk, environmental liability, cyber to a smaller
extend and we see Lloyd's continuing to put pressure on the market and there are really
kind of two messages at the moment at Lloyd's; the longer Vision which is very
aspirational and very gross driven. The short-term one is clearly a pressure. We expect the
SBS business to be tough one and business plans to be hard pushed by Lloyd's as well. So
we would not grow so much in channel, the focus there is very specifically, profitability of
the Group.

A - Ian Kelly

{BIO 19976646 <GO>}

Okay, thanks. Thanks Sami. Let's go to the next question please.

Page 15 of 20



Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

Operator
Our next question comes from Frank Kopfinger from Deutsche Bank. Please go ahead.

FINAL

Q - Frank Kopfinger

Yes, good morning, everybody. I have two questions on the investment side. First is on
your reduction in corporate bonds by 4 percentage points? I was surprised to see that this
only turned out in EUR9 million of realized gains on the bonds. So the question is whether
there were other effects offsetting this? I would have expected, as you reduce your
corporate bond exposure significantly in the last quarter that the realized gains should
turn out to be higher. And then secondly, on unrealized gains on equities, in Q2, I realized
that there was a decline and you have now even a negative unrealized gains number for
equities, despite having a slightly positive equities market in Q2 and could you also
comment on the drivers there?

A - Denis Kessler

Bloomberg Transcript

{BIO 16342277 <GO>}

{BIO 1498477 <GO>}

So, on the -- maybe on the second part that, just the evolution of -- you know that equity
portfolio is mainly invested in convertible bonds and the few recurring investments that
are listed and adjusted the evolution of one line specifically on this portfolio. On your first
question on corporate bond, so that was more a tactical move that we did. If you look at
all the detail in the appendices of the presentation, most of what we did was to reduce a
little bit our exposure to BBB issuers and high yield issuers during the quarter. So, which
mean that the amount of -- realized capital gain was not the the objective, and is limited.
The good news of the decrease of interest rate is that as you can see also in the
appendix, since the beginning of the year, we have almost an increase by EUR600 million
of annualized gain on the fixed income portfolio, which benefit to the Group. Again, I will
give you a full update on what we're going to do over the next few years, given the
current and I would say, new economic environment.

Q - Frank Kopfinger

{BIO 16342277 <GO>}

Okay, thanks.

A - Ian Kelly

{BIO 19976646 <GO>}

Thanks Frank. The next question please.

Operator
We will now take our next question from James Shuck from Citi. Please go ahead.

Q - James Shuck

{BIO 3680082 <GO>}

Hi, good morning everybody. Two questions please. Just on the, the ceding commissions
that you mentioned on one of the questions earlier on, could you just elaborate a little bit
about why the ceding commissions are trending down on casualty, but not so much on the
cat side of the portfolio, please, in the US?

Page 16 of 20



FINAL

Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

And secondly on the reinvestment yield, so the 2.2% obviously, you have the US treasuries
around the 2% level. When it comes to Europe, the reinvestment rates are far lower than
that. Corporate bonds in particular have seen spread narrowing such that we thought of
maybe around 50 basis points on the single A, something like that. Could you just talk a
little bit about the risk-adjusted returns on capital that you're getting for the returns in
corporate bonds related to other asset classes. And does it come a point, at some stage,
certainly in Europe, at which it doesn't make any sense to buy any corporate bonds at all,
but you need to start moving into, say some real or even more into (inaudible) assets for
example? Thank you.

A - Denis Kessler

{BIO 1498477 <GO>}

So, good point on the year on the investment yield. So just, as a reminder, what we call
reinvestment yield, that's the market yield of the portfolio the last day of the quarter. So if
we deploy EUR1 or $1 marginally in the portfolio with the same asset allocation, that would
be the new book yield of this marginal euro or dollar invested. So again, with the mix of
currency we've got the average theoretical reinvestment yield at the end of the quarter is
to 2.2. We have more than 50% of the portfolio invested in dollar. In dollar our
reinvestment yield is at 2.8% at the end of June compared to 2.1% in euro at the end of
June.

Bloomberg Transcript

Again -- or let's say on new target asset allocation, and again given the current economic
and financial environment, you have to wait a few weeks, I will disclose this early
September.

A - Jean-Paul Conoscente

{BIO 20770277 <GO>}

On the question on commission, I think the market dynamics on casualty and property are
different. There's still a lot of reinsurance providing proportional capacity for property
programs and as a result, the brokers are able to keep commission relatively stable. I
think on the casualty side, especially on lines of business where the loss cost has been
increasing, there is less abundance of capacity and reinsurers are better able to push
through overall improvements, not just the price increases.

Q - James Shuck

{BIO 3680082 <GO>}

Okay, could I just clarify, well, I'm not sure I got those numbers incorrect, but you're just
saying we money yields in the US was 2.8% as end of June. In Europe, it's 2.1%, but as we
said the mix is roughly 50% US. So I don't quite see how that gets you to 2.2?

A - Denis Kessler

{BIO 1498477 <GO>}

Yes, because if we look at the other currencies in Sterling, so again, if you want the split of
our portfolio per currency, so the portfolio at the end of June is invested, again it's not a
bet, it's just the pure congruency between assets and liabilities. So the portfolio is
invested 49% in dollar, only 28% in euro, 7% in GBP, 4% in Canadian dollar and the rest in
other currencies. So in GBP, our investment rate is 1.4% and in other currencies, it's 1%. So
it's coming from, let's say, the 1% is coming from the small part of the portfolio let's say
are non-core currencies.

Page 17 of 20



Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

Q - James Shuck

{BIO 3680082 <GO>}

I see. I see, and it still makes sense to buy corporate bonds, single A corporate bonds in
Europe?

FINAL

A - Denis Kessler

{BIO 1498477 <GO>}

If you look at the amount of liquidity that we've got at the end of June in our portfolio
which, you point of view, it's tough to be expensive.

Q - James Shuck

{BIO 3680082 <GO>}

So what you buy instead if you can't buy European corporate bonds?

A - Denis Kessler

{BIO 1498477 <GO>}

Again, wait a few weeks, early September to have the target asset allocation.

Q - James Shuck

{BIO 3680082 <GO>}

Okay. Okay, thank you very much.

A - Ian Kelly

{BIO 19976646 <GO>}

Okay, thanks, James. Are there any further questions?

Bloomberg Transcript

Operator
Yes. Our next question comes from Avinash Goel from Societe Generale. Please go
ahead.

Q - Vikram Gandhi

{BIO 18019785 <GO>}

Hello? Hello, can you hear me?

A - Ian Kelly

{BIO 19976646 <GO>}

Sure. Please go ahead with your question.

Q - Vikram Gandhi

{BIO 18019785 <GO>}

Yes, sorry, it's Vikram from Soc-Gen, using my colleague's phone line. I just got cut out.
I've got just one question. And that's on Solvency II ratio. Appreciate you've already
touched upon on the topic a bit with the business growth and lower interest rates
impacting the SCR. But with the higher liquidity, lower credit risk, tighter spreads and lower
than expected cat impact in second quarter. I'm a bit surprised, the figure of 212%. Just
wondered if you can shed some more light on what drove the decline and if there is any
impact from US modality assumption or experience changes? Thank you.

A - Jean-Paul Conoscente

{BIO 20770277 <GO>}

Page 18 of 20



FINAL

Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

So, biggest drive was declining yields and particularly US yields that worth about 5
percentage points plus or minus of decline in solvency ratio and we added a quarterly
accrual of our planned dividend as in previous quarters, that's worth about 2 percentage
points, that gets you to the 212. There was no particular impact from US modality, there
weren't any significant assumption changes, there are pluses and minus. We have
operating capital generation new business claims experience. This all averages out and
compensates the impact -- sorry, the gross in SCR from -- the business gross. So outside
of financial market movements, and that in total is about neutral on the solvency ratio.

Q - Vikram Gandhi

{BIO 18019785 <GO>}

Okay, thank you very much.

A - Ian Kelly

{BIO 19976646 <GO>}

Okay, thanks very much Vikram. Are there any further questions?

Operator
This concludes today's question and answer session. I'd like to hand the call back to Mr.
Ian Kelly for any additional or closing remarks.

Bloomberg Transcript

A - Ian Kelly

{BIO 19976646 <GO>}

Okay. So, thank you very much for attending the conference call and please don't hesitate
to give us a call if you need any further information. For those who can't attend, we'll be
holding the analyst roundtable at our various European offices later today, but that's at
5:00 PM UK time. And I'll just hand back to Denis for closing remarks.

A - Denis Kessler

{BIO 1498477 <GO>}

Thank you Ian, and thank you all of you for your attention. I would like to wish you a good
summer break. I think we all need it and for those of course, who take some vacation and
we're all looking forward to the presentation of our new strategic plan. The name of it is
Quantum Leap on September 4 during IR Day in Paris and you will have further answers to
your absolutely legitimate questions, but you will have to wait a little bit -- more than a
month, and you would get to full details of the new plans that will cover the next years to
come. So thank you very much and until US summer break. Bye-bye.

Operator
Ladies and gentlemen, this concludes today's call. Thank you for your participation. You
may now disconnect.

This transcript may not be 100 percent accurate and may contain misspellings and other
inaccuracies. This transcript is provided "as is", without express or implied warranties of
any kind. Bloomberg retains all rights to this transcript and provides it solely for your
personal, non-commercial use. Bloomberg, its suppliers and third-party agents shall
Page 19 of 20



Company N ame: SCOR SE
Company Ticker: SCR FP Equity
Date: 2019-07-25

Bloomberg Transcript

FINAL

have no liability for errors in this transcript or for lost profits, losses, or direct, indirect,
incidental, consequential, special or punitive damages in connection with the
furnishing, performance or use of such transcript. Neither the information nor any
opinion expressed in this transcript constitutes a solicitation of the purchase or sale of
securities or commodities. Any opinion expressed in the transcript does not necessarily
reflect the views of Bloomberg LP.  COPYRIGHT 2022, BLOOMBERG LP. All rights
reserved. Any reproduction, redistribution or retransmission is expressly prohibited.

Page 20 of 20

